Literature DB >> 29638208

Investigation of the Cellular Immune Response to Recombinant Fragments of Filamentous Hemagglutinin and Pertactin of Bordetella pertussis in BALB/c Mice.

Peyman Bakhshaei1, Mohammad Hossein Kazemi1, Maryam Golara1, Sara Abdolmaleki1, Roya Khosravi-Eghbal1, Jalal Khoshnoodi1, Mohammad Ali Judaki1, Vahid Salimi2, Masoumeh Douraghi3, Mahmood Jeddi-Tehrani4, Fazel Shokri1,4.   

Abstract

Vaccination with whole-cell or acellular (Ac) vaccines has been very effective for the control of pertussis. The immune response to Ac vaccines has been generally associated with a shift toward the Th2 profile. In the present study, overlapping recombinant fragments of filamentous hemagglutinin (FHA) and pertactin (PRN) were produced in Escherichia coli. BALB/c mice were immunized with recombinant FHA and PRN together with the native pertussis toxin and alum or CpG as adjuvant. Immunized mice were subsequently aerosol challenged with Bordetella pertussis. Bacterial growth was assessed in bronchoalveolar lavage samples and the levels of cytokines were quantitated in supernatants of stimulated splenocytes by enzyme-linked immunosorbent assay. Our results demonstrated that both PRN and FHA antigens were able to induce IFN-γ, IL-4, and to some extent IL-17 cytokines in challenged mice. The level of IFN-γ was higher in response to CpG formulated antigens. These findings indicate immunoprotective efficacy of our recombinant FHA and PRN antigens in mice.

Entities:  

Keywords:  Bordetella pertussis; acellular pertussis vaccine; cellular immunity; filamentous hemagglutinin; pertactin; pertussis infection

Mesh:

Substances:

Year:  2018        PMID: 29638208     DOI: 10.1089/jir.2017.0060

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  6 in total

Review 1.  Immunomodulation as a Novel Strategy for Prevention and Treatment of Bordetella spp. Infections.

Authors:  Monica C Gestal; Hannah M Johnson; Eric T Harvill
Journal:  Front Immunol       Date:  2019-12-13       Impact factor: 7.561

2.  Plasma levels of norepinephrine and expression levels of ß2-adrenergic receptor gene correlate with the incidence of acute graft-versus-host disease.

Authors:  Zahra Momeni-Varposhti; Mohammad Hossein Kazemi; Mehdi Talebi; Rouzbeh Chegeni; Elham Roshandel; Abbas Hajifathali; Ali Akbar Movassaghpour
Journal:  Med J Islam Repub Iran       Date:  2020-11-09

Review 3.  Oncolytic Virotherapy in Solid Tumors: The Challenges and Achievements.

Authors:  Ke-Tao Jin; Wen-Lin Du; Yu-Yao Liu; Huan-Rong Lan; Jing-Xing Si; Xiao-Zhou Mou
Journal:  Cancers (Basel)       Date:  2021-02-03       Impact factor: 6.639

Review 4.  Chemotherapy reinforces anti-tumor immune response and enhances clinical efficacy of immune checkpoint inhibitors.

Authors:  Lin Zhang; Chao Zhou; Songou Zhang; Xiaozhen Chen; Jian Liu; Fangming Xu; Wenqing Liang
Journal:  Front Oncol       Date:  2022-08-08       Impact factor: 5.738

5.  The role of serum uric acid in the prediction of graft-versus-host disease in allogeneic hematopoietic stem cell transplantation.

Authors:  Katayoon Ghasemi; Sayeh Parkhideh; Mohammad Hossein Kazemi; Maryam Salimi; Sina Salari; Ronak Nalini; Abbas Hajifathali
Journal:  J Clin Lab Anal       Date:  2020-03-02       Impact factor: 2.352

6.  Risk Factors of Graft-Versus-Host Disease in the Iranian Allogeneic Hematopoietic Stem Cell Transplantation: A 10-Year Experience.

Authors:  Mahshid Mehdizadeh; Sayeh Parkhideh; Sina Salari; Elham Roshandel; Mohammad Hossein Kazemi; Hossein Bonakchi; Masoud Soleimani; Abbas Hajifathali
Journal:  Med J Islam Repub Iran       Date:  2021-11-02
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.